Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

DiabetOmics

Request full access

Non-invasive assessment and management of personalized health and diabetes risk

Hillsboro, United StatesFounded 2008Health Tech & Medtech

About DiabetOmics

Diabetomics, Inc. is a global medical diagnostics company that specializes in developing innovative, non-invasive tests for early detection of various health conditions. The company is particularly focused on diabetes and maternal health. Diabetomics offers the first and only point-of-care saliva tests for diabetes, which means these tests can be done quickly and easily at the location where the patient is receiving care, without the need for a lab. They also provide early detection tests for preeclampsia (a pregnancy complication) and gestational diabetes, as well as for type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA).

The company operates in the medical diagnostics market, serving healthcare providers, clinics, and potentially individual consumers who need quick and reliable testing solutions. Diabetomics' business model revolves around selling these diagnostic tests to healthcare facilities and directly to consumers. They make money by manufacturing and distributing these tests, leveraging their proprietary technology to offer unique products that are not available from other companies.

In response to the COVID-19 pandemic, Diabetomics has adapted its oral fluid rapid test technology to develop a home-use SARS-CoV-2 antibody test, which can help individuals determine if they have been exposed to the virus.

Diabetomics is ISO 13485:2016 and I.S. EN ISO 13485:2016 certified, which means they meet international standards for quality management systems in the medical device industry. This certification assures clients and partners of the reliability and quality of their products.

Source: Dealroom company data

At a glance

Founded
2008
Headquarters
Hillsboro, United States
Sector
Health Tech & Medtech

DiabetOmics in the Hillsboro ecosystem

Live from Dealroom

The DiabetOmics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Rogue Venture Partners

Series B and later1 investor entered at this stage

  • Ventureast
Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States50%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about DiabetOmics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See DiabetOmics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.